NASDAQ:VNDA

Vanda Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy VNDA

*Your capital is at risk

$5.10

-0.0800 (-1.54%)

At Close: Jul 31, 2026

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA

04:00pm, Monday, 07'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA). Such investors are ad

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA

12:00pm, Saturday, 05'th Oct 2024

NEW YORK, NY / ACCESSWIRE / October 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA). Such investors are ad

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA

10:45am, Thursday, 03'rd Oct 2024

NEW YORK , Oct. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ: VNDA). Such investors are a

Vanda Pharmaceuticals Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - VNDA

07:30am, Wednesday, 02'nd Oct 2024

NEW YORK, NY / ACCESSWIRE / October 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) conc

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Vanda Pharmaceuticals Inc. - VNDA

03:30pm, Tuesday, 01'st Oct 2024

NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA). Such investors are ad

VNDA ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Vanda Pharmaceuticals Inc. Shareholders Who Lost Money

07:25am, Tuesday, 01'st Oct 2024

NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) conc

Levi & Korsinsky Reminds Vanda Pharmaceuticals Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws – VNDA

07:30am, Monday, 30'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

Shareholders That Lost Money on Vanda Pharmaceuticals Inc. (VNDA) Should Contact Levi & Korsinsky About Securities Fraud Investigation - VNDA

07:30am, Friday, 27'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

Vanda Pharmaceuticals Inc. Being Investigated on Behalf of Vanda Pharmaceuticals Inc. Investors. Contact Levi & Korsinsky For Details.

07:25am, Thursday, 26'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

ATTENTION VNDA SHAREHOLDERS: Investors who lost money on Vanda Pharmaceuticals Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

07:30am, Wednesday, 25'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Vanda Pharmaceuticals Inc. (VNDA)

07:30am, Tuesday, 24'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

Vanda Pharmaceuticals Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VNDA

07:20am, Monday, 23'rd Sep 2024

NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis

12:41pm, Friday, 20'th Sep 2024

The FDA issues a complete response letter to Vanda's new drug application for tradipitant for treating symptoms in gastroparesis.

Vanda Pharmaceuticals Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - VNDA

09:45am, Friday, 20'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vanda Pharmaceuticals Inc. ("Vanda Pharmaceuticals Inc.") (NASDAQ:VNDA) c

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

05:20pm, Thursday, 19'th Sep 2024

The biotech had discouraging news to report about one of its pipeline drugs. The FDA declined to approve its application.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by